RT Journal Article SR Electronic T1 Palliative Radiotherapy During the Last Month of Life: Have COVID-19 Recommendations Led to Reduced Utilization? JF In Vivo JO In Vivo FD International Institute of Anticancer Research SP 649 OP 652 DO 10.21873/invivo.12304 VO 35 IS 1 A1 NIEDER, CARSTEN A1 HAUKLAND, ELLINOR C. A1 MANNSAKER, BARD A1 YOBUTA, ROSALBA YR 2021 UL http://iv.iiarjournals.org/content/35/1/649.abstract AB Background/Aim: The study aimed to evaluate practice changes in the time period of the early wave of the COVID-19 pandemic. Patients and Methods: This was a retrospective single institution study. We defined palliative radiotherapy (PRT) initiated before Saturday, March 14th as pre-COVID and PRT initiated later as during-COVID (through June 30th). Results: National COVID-19 recommendations led to a significant decrease in PRT with 10 or more fractions, while re-irradiation and radiotherapy during the final 30 days of life were equally common before and after these recommendations had been issued in March 2020. Conclusion: Rapid adoption of modified PRT regimens was feasible. However, the challenge of overtreatment in the final phase of the disease, due to inaccurate survival prediction, persisted.